Análisis de decisión multicriterio en programas de tratamiento de sustitución de opiáceos en trastornos por consumo de opiáceos
Análisis de decisión multicriterio en programas de tratamiento de sustitución de opiáceos en trastornos por consumo de opiáceos, 2018. Castellà (98.39Kb)
The adoption of new health care interventions offering innovative profiles regarding efficacy and safety but with a greater financial impact compared to previously used treatments is associated with increased health care costs. Other criteria alongside traditional clinical evidence are thus necessary for effective decision making. A prime example of this is health care efficiency assessment, with which the relationship between the health outcomes of new therapeutic options and their costs can be established. The fundamental aim of a value-based health system is to achieve the best health outcomes for patients at an acceptable and sustainable cost to the system. It is thus essential to measure and compare the health-related results of the strategies used with a given pathology (Porter, 2010, McMahon & Chopra, 2012). However, there are other additional criteria in decision making, such as social relevance, prevalence and incidence of the diseases, degree of innovation, comparative effectiveness, medical needs not covered, individual decisions or patient preferences, satisfaction with treatment, number of patients affected, empowerment of patients and principles of fairness. That is to say, considering the large number of criteria involved in any given disease and how to approach it, there will be substantial differences of opinion in many cases among the HCPs who treat it, the decision-makers or political actors who provide resources for its treatment, and the patients who suffer it.
Opioid use disorder; Opioid substitution treatment programs; Multi-criteria decision analysis; Discrete elections experiment
Bobes J, Pascual F, Sabater E, Colom J, Ferre F, Szerman N, et al. Análisis de decisión multicriterio en programas de tratamiento de sustitución de opiáceos en trastornos por consumo de opiáceos. Adicciones. 2018 Jul 12;30(3):167-169.
Use this identifier for quote and/or link this documenthttps://hdl.handle.net/11351/6981
This item appears in following collections
The following license files are associated with this item: